FOXO Technologies: Funding, Investors & Team (Oct 2026)
FOXO Technologies is revolutionizing the longevity insurance industry worldwide by utilizing cutting-edge underwriting methods and consumer engagement tools that are founded on epigenetic technology and knowledge. The company employs AI-driven bioinformatics and microarray technologies to create and market epigenetic biomarkers for health and aging, offering laboratory services, microarray design, and bioinformatics software solutions to insurers, health researchers, and life science companies to access unique information on lifespan.
FOXO Technologies has raised $4.5M across 3 funding rounds on record, the most recent an undisclosed round of $1.5M announced in Jun 2025.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
FOXO Technologies Company Profile and Key Stats
Latest funding round on record: Jun 2025.
FOXO Technologies Funding Rounds
FOXO Technologies raised $2.8M in an undisclosed round announced in Jun 2024.
6 months later, an undisclosed round of $220k was announced in Dec 2024.
6 months later, an undisclosed round of $1.5M was announced in Jun 2025.
FOXO Technologies Founders and Leadership Team
Contact details for the FOXO Technologies team: 1 of 1 has an email address on file.
Start 14-day free trial →FOXO Technologies Funding Compared to Other Biotechnology Startups
FOXO Technologies' latest round of $1.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like FOXO Technologies in Biotechnology and Minneapolis
Companies Similar to FOXO Technologies
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
FOXO Technologies Funding FAQs
What does FOXO Technologies do?
FOXO Technologies is revolutionizing the longevity insurance industry worldwide by utilizing cutting-edge underwriting methods and consumer engagement tools that are founded on epigenetic technology and knowledge. The company employs AI-driven bioinformatics and microarray technologies to create and market epigenetic biomarkers for health and aging, offering laboratory services, microarray design, and bioinformatics software solutions to insurers, health researchers, and life science companies to access unique information on lifespan.
How much funding has FOXO Technologies raised?
FOXO Technologies has raised $4.5M across 3 rounds on record. The most recent is an undisclosed round of $1.5M announced in Jun 2025.
When did FOXO Technologies last raise funding?
FOXO Technologies' most recent funding round on record is an undisclosed round of $1.5M, announced in Jun 2025.
Who founded FOXO Technologies?
FundedIQ lists Jon R Sabes (Founder) at FOXO Technologies.
Where is FOXO Technologies headquartered?
FOXO Technologies is based in Minneapolis, Minnesota, United States.
How many employees does FOXO Technologies have?
FOXO Technologies is in the 1-10 employee band.
How does FOXO Technologies' funding compare to other Biotechnology startups?
FOXO Technologies' latest round of $1.5M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's FOXO Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for FOXO Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.